BioCentury
ARTICLE | Clinical News

Olinvo: Ph III APOLLO-2 data

February 24, 2017 7:01 PM UTC

Top-line data from the double-blind, U.S. Phase III APOLLO-2 trial in 401 patients with moderate to severe acute pain following abdominoplasty showed that 0.1, 0.35 and 0.5 mg IV Olinvo as needed each...

BCIQ Company Profiles

Trevena Inc.